Clinical Trial Update: Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population [Phase 4]

View source ↗

Summary

Phase 4 pediatric epilepsy trial evaluating Depakote ER in children with intellectual disability and developmental disabilities has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental Disabilities
• Epilepsy
• Intellectual Disability

Drugs mentioned

• DEPAKOTE ER (DIVALPROEX SODIUM)

Snippet

Sponsor: Children's National Research Institute | Conditions: Epilepsy, Mental Retardation | Phase 4 | Status: COMPLETED